Press release
Sufentanil - API Insight, 2018 | Aphios Corporation, Deltanoid Pharmaceuticals, Xeragenx LLC
Sufentanil, sold under the brand names of Dsuvia and Sufenta, is basically a synthetic opioid analgesic drug, which is used for the medication of acute pain relief. It helps to offer properties of sedation and this makes it a good analgesic component of anesthetic regimen during a surgical process.Download the sample report at: https://www.pharmaproff.com/request-sample/1167
It has greater potency than morphine and Fentanyl, often used in surgery and post-operative pain management for patients that are heavily opioid dependent or tolerant because of long term opiate use for chronic pain or illicit opiate use. In the present market, Sufentanil has proven to be the strongest opioid painkiller available.
Get the detailed analysis at: https://www.pharmaproff.com/report/sufentanil
In 2018, the Food and Drug Association had approved Dsuvia, a sublingual tablet form of the drug, that was developed in a collaboration between AcelRx Pharmaceuticals Inc. and the United States Department of Defense for use in battlefield settings where intravenous treatments may not be available. Some of the side-effects include heart rhythm irregularity, blood pressure changes and nausea/vomiting.
Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1167
This report provides details of the drug and the API manufacturers across the 7 major markets which includes U.S, EU5, and Japan. It includes the overview, mechanism, regulatory milestones, strategic developments, the historical and forecasted sales. The pipeline analysis of the drug by phase which would include the product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology and others.
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sufentanil - API Insight, 2018 | Aphios Corporation, Deltanoid Pharmaceuticals, Xeragenx LLC here
News-ID: 1726593 • Views: β¦
More Releases for Sufenta
Global Managed Detection and Response (MDR) Software Market Size, Share and Fore β¦
πππ, πππ° πππ«π¬ππ²- According to the Market Research Intellect, the global Managed Detection and Response (MDR) Software market is projected to grow at a robust compound annual growth rate (CAGR) of 16.77% from 2024 to 2031. Starting with a valuation of 5.84 Billion in 2024, the market is expected to reach approximately 14.8 Billion by 2031, driven by factors such as Managed Detection and Response (MDR) Software and Managed Detectionβ¦
Medical Disposable Plastic Face Shield Market Size, Share and Forecast By Key Pl β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Medical Disposable Plastic Face Shield market is anticipated to grow at a compound annual growth rate (CAGR) of 15.53% between 2024 and 2031. The market is expected to grow to USD 36 Billion by 2024. The valuation is expected to reach USD 98.9 Billion by 2031.
The medical disposable plastic face shield market has experienced significant growth, particularlyβ¦
Carbon Steel Seamless Steel Pipe Market Size, Share and Forecast By Key Players- β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Carbon Steel Seamless Steel Pipe market is anticipated to grow at a compound annual growth rate (CAGR) of 13.54% between 2024 and 2031. The market is expected to grow to USDΒ 27.57Β Billion by 2024. The valuation is expected to reach USDΒ 67.05Β Billion by 2031.
The market for carbon steel seamless steel pipe is expanding rapidly due to rising demand fromβ¦
LTE Advanced Pro Market Set for Rapid Growth and Trend by 2021-2027 Covid-19 Ana β¦
LTE Advanced Pro market Research Report works on strategic research methodology, which greatly helps organizations to generate profits and get success in the global market. Market Research Analysis also depicts visionary innovations, future scenarios and market forecasts to drive important actions for leading business. It also focuses on marketing strategy which helps breaking a huge market into small segments to target customers. It also points out customer demands helps toβ¦